Current Studies Data updated on 24 Nov 2016
No Study Name/Phase Type Sponsor Enrolled Period
1 HPV vaccine /Phase III HPV vaccine MSD 20 2010-2018
2 TB-018/Phase III TB Vaccine Aeras/GSK 468  2014-2018
3 Menacwy/Phase III Menengococccal vaccine Pfizer 86 2014-2019
4 ECHO/Phase III HIV risk with Contraception FHI360/UW 320  2015-2018
5 STAND Study/Phase III TB Drug therapy TB alliance 12 2015 –
6 HVTN 100/Phase I/II HIV Vaccine DAIDS 44 2015 – 2018
7 TRIO MPT Acceptability RTI 140 2015 -2016
8 RSV (Season 1)/Phase III RSV Vaccine Novavax 36 2015 -2017
9 HVTN702 HIV Vaccine HVTN 7 2016 – 2021
10 RSV (Season 2) /Phase III RSV Vaccine Novavax 24 2016 –  2018
Future Studies Data updated on 24 Nov 2016
No Study Name/Phase Type Sponsor Number to be enrolled Duration
1 HDT TB TB Treatment ACT4TB/ Aurum 50 Dec 2016 – Mar 2018
2 Oral Candidiasis Oral Candida Treatment Aspen 28 Dec 2016 – Jul 2017
3 HVTN108 HIV Vaccine HVTN 18 Jan 2017 – Jan 2019